Enter Note Done
Go to previous page in this tab
Session
  • Platform Talks
  • Bookmark Icon
  • Diverse Epigenetic Marks in Health, Diagnosis, and Disease
  • Schedule
    Notes
  • Location IconRoom 505
    Session 46
    Set Timezone

To see live captions during this session on your device, click here: https://www.streamtext.net/player?event=Room-fivezerosix

Epigenomic marks and complexes contribute to development and disease. This session covers the convergence of pathogenic variants with epigenomics and epitranscriptomics. Novel approaches to detect differential DNA methylation and variant classification are evaluated. The malleability of the epigenome to reverse clinical features of developmental disorders is examined.

Learning Objectives:
1. Assess novel relationships between the histone modification landscape and epigenomic functions.
2. Evaluate m6A methylation relative to brain development and disease.
3. Summarize the genetic impact of DNA methylation changes shared across multiple tissues.
4. Compare sequencing technologies' ability to detect rare methylation differences from genome data.
5. Define single-cell methods for variant classification in rare epilepsies.
6. Evaluate the in utero malleability of Wiedemann-Steiner syndrome.

Session Type
Audience
CME
Track
Presentations